The cartridges were eluted with 5 x 1 ml methanol/sodium citrate solution
0.1 M (25/75) and collected into a 5 ml graduated tube.
To examine whether USP-generated AuNPs behave similarly, the UV-vis spectra of AuC18 and AuC20 in citrate solution
and after their incubation in the complete RPMI medium for 2h or 24 h were analyzed (Figure 4(a)).
In each case, the dilutions were done with either the citrate solution
(for the C series) or 1 mol x [L.sup.-1] HCl (for the A series).
VF-054SBCS07 [Terumo Venosafe[TM] plastic, containing 0.4 mL of buffered sodium citrate solution
(32 g/L; final concentration, 0.109 mol/L), hereafter called tube 2;
(10) and corresponds with what one would theoretically expect when 1 part citrate solution
and 9 parts blood with a hematocrit of 42% are taken together (11).
367702, 9NC; Becton Dickinson) containing 0.35 mL of 0.129 mol/L (3.8%) citrate solution
(blood volume, 3.15 mL), and 157 patients were sampled with a citrate coagulation tube (Vacuette cat.
367702, 9NC; Becton Dickinson) contained 0.35 mL of 0.129 mol/L citrate solution
and had a blood volume of 3.15 mL.
Because addition of citrate solution
to the blood diluted the plasma, the D-Dimer concentrations in citrated plasma were lower than in heparinized plasma (found median difference was 16%, which corresponded to an estimated plasma fraction of 58%, or a 42% hematocrit).